Inactivation of non-enveloped virus by 1,5 iodonaphthyl azide. 2015

Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. paridhi.gupta.ctr@usuhs.edu.

BACKGROUND A photoactive hydrophobic agent 1,5-iodonaphthyl-azide (INA), has been previously shown to completely inactivate the enveloped viruses. INA sequesters into the lipid bilayer of the virus envelope and upon UV-irradiation bind to the hydrophobic domains of the envelope glycoproteins. In our earlier study, we have shown that the Venezuelan equine encephalitis virus (VEEV) genomic RNA was also inactivated during the inactivation of the virus with INA. RESULTS In the present study, we evaluated if the RNA inactivation property of INA can be used to inactivate non-enveloped RNA viruses. Encephalomyocarditis virus (EMCV) was used as a model non-enveloped virus. Treatment with INA followed by UV-irradiation resulted in complete inactivation of EMCV. RNA isolated from INA-inactivated EMCV was non-infectious and INA was found to be associated with the viral RNA genome. INA-inactivated EMCV induced robust total antibody response. However binding capacity of INA-inactivated EMCV to neutralizing antibody was inhibited. CONCLUSIONS This is the first study to show that INA can completely inactivate non-enveloped virus. Our results suggest that the amino acid composition of the neutralizing epitope may interfere with the protective antibody response generated by the INA-inactivated non-enveloped virus.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004686 Encephalomyocarditis virus The type species of CARDIOVIRUS causing encephalomyelitis and myocarditis in rodents, pigs, and monkeys. Infection in man has been reported with CNS involvement but without myocarditis. EMCV
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001386 Azides Organic or inorganic compounds that contain the -N3 group. Azide
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA

Related Publications

Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
October 2019, Pathogens (Basel, Switzerland),
Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
January 1979, Antimicrobial agents and chemotherapy,
Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
November 2021, Life (Basel, Switzerland),
Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
December 2021, Bioconjugate chemistry,
Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
December 2012, Journal of biomedical optics,
Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
August 2012, Cell and tissue banking,
Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
February 2014, Virology journal,
Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
July 1998, Haemophilia : the official journal of the World Federation of Hemophilia,
Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
December 2018, Journal of photochemistry and photobiology. B, Biology,
Paridhi Gupta, and Anuj Sharma, and Viard Mathias, and Yossef Raviv, and Robert Blumenthal, and Radha K Maheshwari
March 2020, Biotechnology progress,
Copied contents to your clipboard!